Department of Obstetrics and Gynecology, Erasmus MC - Sophia Children's Hospital, Rotterdam, the Netherlands; Prinses Máxima Centrum for Pediatric Oncology, Utrecht, the Netherlands.
School of Computer Science, University of St. Andrews, North Haugh, St. Andrews, UK.
Eur J Cancer. 2019 Apr;111:126-137. doi: 10.1016/j.ejca.2019.01.104. Epub 2019 Mar 5.
Observational studies have suggested that perinatal outcomes are worse in offspring of cancer survivors. We conducted a systematic review and meta-analysis to examine the risks of perinatal complications in female cancer survivors diagnosed before the age of 40 years.
All published articles on pregnancy, perinatal or congenital risks in female cancer survivors were screened for eligibility. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed.
Twenty-two studies met the inclusion criteria. Meta-analysis indicates that offspring of cancer survivors are at increased risk of prematurity (relative risk [RR]: 1.56; 95% confidence interval [CI] 1.37-1.77) and low birth weight (RR 1.47; 95% CI 1.24-1.73) but not of being small for gestational age (RR 0.99; 95% CI 0.81-1.22). Cancer survivors have higher rates of elective (RR: 1.38; 95% CI 1.13-1.70) and emergency caesarean section (RR: 1.22; 95% CI 1.15-1.30) as well as assisted vaginal delivery (RR: 1.10; 95% CI 1.02-1.18) and are at increased risk of postpartum haemorrhage (RR: 1.18; 95% CI 1.02-1.36). The risk of congenital abnormalities also appears increased (RR 1.10; 95% CI 1.02-1.20), but this is likely to be an artefact of analysis. Although meta-analysis of the effects of radiotherapy was not possible for all outcomes, there was an increased risk of prematurity (RR 2.27; 95% CI 1.34-3.82) and consistent findings of low birth weight (RR 1.38-2.31). Risk of being small for gestational age was increased only after high uterine radiotherapy dosage.
The increased perinatal risks warrant a proactive approach from healthcare providers in both counselling and management of perinatal care for cancer survivors.
观察性研究表明,围产期结局在癌症幸存者的后代中较差。我们进行了一项系统评价和荟萃分析,以检查 40 岁以下诊断为女性癌症幸存者的围产期并发症风险。
筛选所有关于妊娠、围产期或先天性风险的已发表文章,以确定其是否符合纳入标准。本研究遵循系统评价和荟萃分析的首选报告项目的指南。
22 项研究符合纳入标准。荟萃分析表明,癌症幸存者的后代早产风险增加(相对风险 [RR]:1.56;95%置信区间 [CI]:1.37-1.77)和低出生体重(RR 1.47;95% CI:1.24-1.73),但不是胎儿生长受限(RR 0.99;95% CI:0.81-1.22)。癌症幸存者选择性剖宫产(RR:1.38;95% CI:1.13-1.70)和紧急剖宫产(RR:1.22;95% CI:1.15-1.30)以及辅助阴道分娩(RR:1.10;95% CI:1.02-1.18)的发生率更高,产后出血的风险也更高(RR:1.18;95% CI:1.02-1.36)。先天性异常的风险似乎也增加(RR 1.10;95% CI:1.02-1.20),但这可能是分析的一种假象。尽管无法对所有结果进行放疗效果的荟萃分析,但早产风险增加(RR 2.27;95% CI:1.34-3.82)和低出生体重的一致发现(RR 1.38-2.31)。只有在高子宫放疗剂量后,胎儿生长受限的风险才会增加。
围产期风险增加,需要医疗保健提供者在为癌症幸存者提供围产期护理咨询和管理方面采取积极主动的方法。